aluates Reports

$ 0.0

Automative

Global Drug Delivery in Cancer Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-10B3055

Global Drug Delivery in Cancer Market Insights Forecast to 2028

BUY CHAPTERS

Global Drug Delivery in Cancer Market Research Report 2024

Code: QYRE-Auto-10B3055

Report

April 2024

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Drug Delivery in Cancer Market

The global Drug Delivery in Cancer market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Drug Delivery in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Drug Delivery in Cancer is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Drug Delivery in Cancer in Hospitals & Clinic is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Drug Delivery in Cancer include Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson and Takeda, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Drug Delivery in Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery in Cancer.

Report Scope

The Drug Delivery in Cancer market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery in Cancer market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Delivery in Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Delivery in Cancer Market Report

Report Metric	Details
Report Name	Drug Delivery in Cancer Market
Segment by Type	Liposomes PEGylated Proteins & Polypeptides Polymer Nanoparticle Protein–drug Conjugates Others
Segment by Application	Hospitals & Clinic Cancer Treatment Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson, Takeda, Gilead Sciences, Pfizer, Dr Reddy, Samyang Biopharmaceuticals, Tolmar, Astellas, AMAG Pharmaceuticals, AstraZeneca, AbbVie, Novartis, Aspen, Shire (Baxalta), Breckenridge Pharmaceuticals, Galen Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery in Cancer companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug Delivery in Cancer Market report?

Ans: The main players in the Drug Delivery in Cancer Market are Amgen, Teva, UCB (Union Chimique Belge), Roche, Celgene, Sanofi, Merck, Johnson & Johnson, Takeda, Gilead Sciences, Pfizer, Dr Reddy, Samyang Biopharmaceuticals, Tolmar, Astellas, AMAG Pharmaceuticals, AstraZeneca, AbbVie, Novartis, Aspen, Shire (Baxalta), Breckenridge Pharmaceuticals, Galen Pharmaceuticals

What are the Application segmentation covered in the Drug Delivery in Cancer Market report?

Ans: The Applications covered in the Drug Delivery in Cancer Market report are Hospitals & Clinic, Cancer Treatment Centers, Others

What are the Type segmentation covered in the Drug Delivery in Cancer Market report?

Ans: The Types covered in the Drug Delivery in Cancer Market report are Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Delivery in Cancer Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Liposomes

1.2.3 PEGylated Proteins & Polypeptides

1.2.4 Polymer Nanoparticle

1.2.5 Protein–drug Conjugates

1.2.6 Others

1.3 Market by Application

1.3.1 Global Drug Delivery in Cancer Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals & Clinic

1.3.3 Cancer Treatment Centers

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Delivery in Cancer Market Perspective (2019-2030)

2.2 Drug Delivery in Cancer Growth Trends by Region

2.2.1 Global Drug Delivery in Cancer Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drug Delivery in Cancer Historic Market Size by Region (2019-2024)

2.2.3 Drug Delivery in Cancer Forecasted Market Size by Region (2025-2030)

2.3 Drug Delivery in Cancer Market Dynamics

2.3.1 Drug Delivery in Cancer Industry Trends

2.3.2 Drug Delivery in Cancer Market Drivers

2.3.3 Drug Delivery in Cancer Market Challenges

2.3.4 Drug Delivery in Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Delivery in Cancer Players by Revenue

3.1.1 Global Top Drug Delivery in Cancer Players by Revenue (2019-2024)

3.1.2 Global Drug Delivery in Cancer Revenue Market Share by Players (2019-2024)

3.2 Global Drug Delivery in Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drug Delivery in Cancer Revenue

3.4 Global Drug Delivery in Cancer Market Concentration Ratio

3.4.1 Global Drug Delivery in Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery in Cancer Revenue in 2023

3.5 Drug Delivery in Cancer Key Players Head office and Area Served

3.6 Key Players Drug Delivery in Cancer Product Solution and Service

3.7 Date of Enter into Drug Delivery in Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Delivery in Cancer Breakdown Data by Type

4.1 Global Drug Delivery in Cancer Historic Market Size by Type (2019-2024)

4.2 Global Drug Delivery in Cancer Forecasted Market Size by Type (2025-2030)

5 Drug Delivery in Cancer Breakdown Data by Application

5.1 Global Drug Delivery in Cancer Historic Market Size by Application (2019-2024)

5.2 Global Drug Delivery in Cancer Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drug Delivery in Cancer Market Size (2019-2030)

6.2 North America Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Drug Delivery in Cancer Market Size by Country (2019-2024)

6.4 North America Drug Delivery in Cancer Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Delivery in Cancer Market Size (2019-2030)

7.2 Europe Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Drug Delivery in Cancer Market Size by Country (2019-2024)

7.4 Europe Drug Delivery in Cancer Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Delivery in Cancer Market Size (2019-2030)

8.2 Asia-Pacific Drug Delivery in Cancer Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2019-2024)

8.4 Asia-Pacific Drug Delivery in Cancer Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug Delivery in Cancer Market Size (2019-2030)

9.2 Latin America Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Drug Delivery in Cancer Market Size by Country (2019-2024)

9.4 Latin America Drug Delivery in Cancer Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Delivery in Cancer Market Size (2019-2030)

10.2 Middle East & Africa Drug Delivery in Cancer Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2019-2024)

10.4 Middle East & Africa Drug Delivery in Cancer Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Detail

11.1.2 Amgen Business Overview

11.1.3 Amgen Drug Delivery in Cancer Introduction

11.1.4 Amgen Revenue in Drug Delivery in Cancer Business (2019-2024)

11.1.5 Amgen Recent Development

11.2 Teva

11.2.1 Teva Company Detail

11.2.2 Teva Business Overview

11.2.3 Teva Drug Delivery in Cancer Introduction

11.2.4 Teva Revenue in Drug Delivery in Cancer Business (2019-2024)

11.2.5 Teva Recent Development

11.3 UCB (Union Chimique Belge)

11.3.1 UCB (Union Chimique Belge) Company Detail

11.3.2 UCB (Union Chimique Belge) Business Overview

11.3.3 UCB (Union Chimique Belge) Drug Delivery in Cancer Introduction

11.3.4 UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2019-2024)

11.3.5 UCB (Union Chimique Belge) Recent Development

11.4 Roche

11.4.1 Roche Company Detail

11.4.2 Roche Business Overview

11.4.3 Roche Drug Delivery in Cancer Introduction

11.4.4 Roche Revenue in Drug Delivery in Cancer Business (2019-2024)

11.4.5 Roche Recent Development

11.5 Celgene

11.5.1 Celgene Company Detail

11.5.2 Celgene Business Overview

11.5.3 Celgene Drug Delivery in Cancer Introduction

11.5.4 Celgene Revenue in Drug Delivery in Cancer Business (2019-2024)

11.5.5 Celgene Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Detail

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Drug Delivery in Cancer Introduction

11.6.4 Sanofi Revenue in Drug Delivery in Cancer Business (2019-2024)

11.6.5 Sanofi Recent Development

11.7 Merck

11.7.1 Merck Company Detail

11.7.2 Merck Business Overview

11.7.3 Merck Drug Delivery in Cancer Introduction

11.7.4 Merck Revenue in Drug Delivery in Cancer Business (2019-2024)

11.7.5 Merck Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Detail

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Drug Delivery in Cancer Introduction

11.8.4 Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2019-2024)

11.8.5 Johnson & Johnson Recent Development

11.9 Takeda

11.9.1 Takeda Company Detail

11.9.2 Takeda Business Overview

11.9.3 Takeda Drug Delivery in Cancer Introduction

11.9.4 Takeda Revenue in Drug Delivery in Cancer Business (2019-2024)

11.9.5 Takeda Recent Development

11.10 Gilead Sciences

11.10.1 Gilead Sciences Company Detail

11.10.2 Gilead Sciences Business Overview

11.10.3 Gilead Sciences Drug Delivery in Cancer Introduction

11.10.4 Gilead Sciences Revenue in Drug Delivery in Cancer Business (2019-2024)

11.10.5 Gilead Sciences Recent Development

11.11 Pfizer

11.11.1 Pfizer Company Detail

11.11.2 Pfizer Business Overview

11.11.3 Pfizer Drug Delivery in Cancer Introduction

11.11.4 Pfizer Revenue in Drug Delivery in Cancer Business (2019-2024)

11.11.5 Pfizer Recent Development

11.12 Dr Reddy

11.12.1 Dr Reddy Company Detail

11.12.2 Dr Reddy Business Overview

11.12.3 Dr Reddy Drug Delivery in Cancer Introduction

11.12.4 Dr Reddy Revenue in Drug Delivery in Cancer Business (2019-2024)

11.12.5 Dr Reddy Recent Development

11.13 Samyang Biopharmaceuticals

11.13.1 Samyang Biopharmaceuticals Company Detail

11.13.2 Samyang Biopharmaceuticals Business Overview

11.13.3 Samyang Biopharmaceuticals Drug Delivery in Cancer Introduction

11.13.4 Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)

11.13.5 Samyang Biopharmaceuticals Recent Development

11.14 Tolmar

11.14.1 Tolmar Company Detail

11.14.2 Tolmar Business Overview

11.14.3 Tolmar Drug Delivery in Cancer Introduction

11.14.4 Tolmar Revenue in Drug Delivery in Cancer Business (2019-2024)

11.14.5 Tolmar Recent Development

11.15 Astellas

11.15.1 Astellas Company Detail

11.15.2 Astellas Business Overview

11.15.3 Astellas Drug Delivery in Cancer Introduction

11.15.4 Astellas Revenue in Drug Delivery in Cancer Business (2019-2024)

11.15.5 Astellas Recent Development

11.16 AMAG Pharmaceuticals

11.16.1 AMAG Pharmaceuticals Company Detail

11.16.2 AMAG Pharmaceuticals Business Overview

11.16.3 AMAG Pharmaceuticals Drug Delivery in Cancer Introduction

11.16.4 AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)

11.16.5 AMAG Pharmaceuticals Recent Development

11.17 AstraZeneca

11.17.1 AstraZeneca Company Detail

11.17.2 AstraZeneca Business Overview

11.17.3 AstraZeneca Drug Delivery in Cancer Introduction

11.17.4 AstraZeneca Revenue in Drug Delivery in Cancer Business (2019-2024)

11.17.5 AstraZeneca Recent Development

11.18 AbbVie

11.18.1 AbbVie Company Detail

11.18.2 AbbVie Business Overview

11.18.3 AbbVie Drug Delivery in Cancer Introduction

11.18.4 AbbVie Revenue in Drug Delivery in Cancer Business (2019-2024)

11.18.5 AbbVie Recent Development

11.19 Novartis

11.19.1 Novartis Company Detail

11.19.2 Novartis Business Overview

11.19.3 Novartis Drug Delivery in Cancer Introduction

11.19.4 Novartis Revenue in Drug Delivery in Cancer Business (2019-2024)

11.19.5 Novartis Recent Development

11.20 Aspen

11.20.1 Aspen Company Detail

11.20.2 Aspen Business Overview

11.20.3 Aspen Drug Delivery in Cancer Introduction

11.20.4 Aspen Revenue in Drug Delivery in Cancer Business (2019-2024)

11.20.5 Aspen Recent Development

11.21 Shire (Baxalta)

11.21.1 Shire (Baxalta) Company Detail

11.21.2 Shire (Baxalta) Business Overview

11.21.3 Shire (Baxalta) Drug Delivery in Cancer Introduction

11.21.4 Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2019-2024)

11.21.5 Shire (Baxalta) Recent Development

11.22 Breckenridge Pharmaceuticals

11.22.1 Breckenridge Pharmaceuticals Company Detail

11.22.2 Breckenridge Pharmaceuticals Business Overview

11.22.3 Breckenridge Pharmaceuticals Drug Delivery in Cancer Introduction

11.22.4 Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)

11.22.5 Breckenridge Pharmaceuticals Recent Development

11.23 Galen Pharmaceuticals

11.23.1 Galen Pharmaceuticals Company Detail

11.23.2 Galen Pharmaceuticals Business Overview

11.23.3 Galen Pharmaceuticals Drug Delivery in Cancer Introduction

11.23.4 Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024)

11.23.5 Galen Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Drug Delivery in Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Liposomes

Table 3. Key Players of PEGylated Proteins & Polypeptides

Table 4. Key Players of Polymer Nanoparticle

Table 5. Key Players of Protein–drug Conjugates

Table 6. Key Players of Others

Table 7. Global Drug Delivery in Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Drug Delivery in Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Drug Delivery in Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Drug Delivery in Cancer Market Share by Region (2019-2024)

Table 11. Global Drug Delivery in Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Drug Delivery in Cancer Market Share by Region (2025-2030)

Table 13. Drug Delivery in Cancer Market Trends

Table 14. Drug Delivery in Cancer Market Drivers

Table 15. Drug Delivery in Cancer Market Challenges

Table 16. Drug Delivery in Cancer Market Restraints

Table 17. Global Drug Delivery in Cancer Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Drug Delivery in Cancer Market Share by Players (2019-2024)

Table 19. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery in Cancer as of 2023)

Table 20. Ranking of Global Top Drug Delivery in Cancer Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Drug Delivery in Cancer Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Drug Delivery in Cancer Product Solution and Service

Table 24. Date of Enter into Drug Delivery in Cancer Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Drug Delivery in Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Drug Delivery in Cancer Revenue Market Share by Type (2019-2024)

Table 28. Global Drug Delivery in Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Drug Delivery in Cancer Revenue Market Share by Type (2025-2030)

Table 30. Global Drug Delivery in Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Drug Delivery in Cancer Revenue Market Share by Application (2019-2024)

Table 32. Global Drug Delivery in Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Drug Delivery in Cancer Revenue Market Share by Application (2025-2030)

Table 34. North America Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Drug Delivery in Cancer Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Drug Delivery in Cancer Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Drug Delivery in Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Drug Delivery in Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 49. Amgen Company Detail

Table 50. Amgen Business Overview

Table 51. Amgen Drug Delivery in Cancer Product

Table 52. Amgen Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 53. Amgen Recent Development

Table 54. Teva Company Detail

Table 55. Teva Business Overview

Table 56. Teva Drug Delivery in Cancer Product

Table 57. Teva Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 58. Teva Recent Development

Table 59. UCB (Union Chimique Belge) Company Detail

Table 60. UCB (Union Chimique Belge) Business Overview

Table 61. UCB (Union Chimique Belge) Drug Delivery in Cancer Product

Table 62. UCB (Union Chimique Belge) Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 63. UCB (Union Chimique Belge) Recent Development

Table 64. Roche Company Detail

Table 65. Roche Business Overview

Table 66. Roche Drug Delivery in Cancer Product

Table 67. Roche Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 68. Roche Recent Development

Table 69. Celgene Company Detail

Table 70. Celgene Business Overview

Table 71. Celgene Drug Delivery in Cancer Product

Table 72. Celgene Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 73. Celgene Recent Development

Table 74. Sanofi Company Detail

Table 75. Sanofi Business Overview

Table 76. Sanofi Drug Delivery in Cancer Product

Table 77. Sanofi Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 78. Sanofi Recent Development

Table 79. Merck Company Detail

Table 80. Merck Business Overview

Table 81. Merck Drug Delivery in Cancer Product

Table 82. Merck Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 83. Merck Recent Development

Table 84. Johnson & Johnson Company Detail

Table 85. Johnson & Johnson Business Overview

Table 86. Johnson & Johnson Drug Delivery in Cancer Product

Table 87. Johnson & Johnson Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 88. Johnson & Johnson Recent Development

Table 89. Takeda Company Detail

Table 90. Takeda Business Overview

Table 91. Takeda Drug Delivery in Cancer Product

Table 92. Takeda Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 93. Takeda Recent Development

Table 94. Gilead Sciences Company Detail

Table 95. Gilead Sciences Business Overview

Table 96. Gilead Sciences Drug Delivery in Cancer Product

Table 97. Gilead Sciences Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 98. Gilead Sciences Recent Development

Table 99. Pfizer Company Detail

Table 100. Pfizer Business Overview

Table 101. Pfizer Drug Delivery in Cancer Product

Table 102. Pfizer Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 103. Pfizer Recent Development

Table 104. Dr Reddy Company Detail

Table 105. Dr Reddy Business Overview

Table 106. Dr Reddy Drug Delivery in Cancer Product

Table 107. Dr Reddy Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 108. Dr Reddy Recent Development

Table 109. Samyang Biopharmaceuticals Company Detail

Table 110. Samyang Biopharmaceuticals Business Overview

Table 111. Samyang Biopharmaceuticals Drug Delivery in Cancer Product

Table 112. Samyang Biopharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 113. Samyang Biopharmaceuticals Recent Development

Table 114. Tolmar Company Detail

Table 115. Tolmar Business Overview

Table 116. Tolmar Drug Delivery in Cancer Product

Table 117. Tolmar Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 118. Tolmar Recent Development

Table 119. Astellas Company Detail

Table 120. Astellas Business Overview

Table 121. Astellas Drug Delivery in Cancer Product

Table 122. Astellas Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 123. Astellas Recent Development

Table 124. AMAG Pharmaceuticals Company Detail

Table 125. AMAG Pharmaceuticals Business Overview

Table 126. AMAG Pharmaceuticals Drug Delivery in Cancer Product

Table 127. AMAG Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 128. AMAG Pharmaceuticals Recent Development

Table 129. AstraZeneca Company Detail

Table 130. AstraZeneca Business Overview

Table 131. AstraZeneca Drug Delivery in Cancer Product

Table 132. AstraZeneca Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 133. AstraZeneca Recent Development

Table 134. AbbVie Company Detail

Table 135. AbbVie Business Overview

Table 136. AbbVie Drug Delivery in Cancer Product

Table 137. AbbVie Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 138. AbbVie Recent Development

Table 139. Novartis Company Detail

Table 140. Novartis Business Overview

Table 141. Novartis Drug Delivery in Cancer Product

Table 142. Novartis Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 143. Novartis Recent Development

Table 144. Aspen Company Detail

Table 145. Aspen Business Overview

Table 146. Aspen Drug Delivery in Cancer Product

Table 147. Aspen Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 148. Aspen Recent Development

Table 149. Shire (Baxalta) Company Detail

Table 150. Shire (Baxalta) Business Overview

Table 151. Shire (Baxalta) Drug Delivery in Cancer Product

Table 152. Shire (Baxalta) Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 153. Shire (Baxalta) Recent Development

Table 154. Breckenridge Pharmaceuticals Company Detail

Table 155. Breckenridge Pharmaceuticals Business Overview

Table 156. Breckenridge Pharmaceuticals Drug Delivery in Cancer Product

Table 157. Breckenridge Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 158. Breckenridge Pharmaceuticals Recent Development

Table 159. Galen Pharmaceuticals Company Detail

Table 160. Galen Pharmaceuticals Business Overview

Table 161. Galen Pharmaceuticals Drug Delivery in Cancer Product

Table 162. Galen Pharmaceuticals Revenue in Drug Delivery in Cancer Business (2019-2024) & (US$ Million)

Table 163. Galen Pharmaceuticals Recent Development

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drug Delivery in Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Drug Delivery in Cancer Market Share by Type: 2023 VS 2030

Figure 3. Liposomes Features

Figure 4. PEGylated Proteins & Polypeptides Features

Figure 5. Polymer Nanoparticle Features

Figure 6. Protein–drug Conjugates Features

Figure 7. Others Features

Figure 8. Global Drug Delivery in Cancer Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Drug Delivery in Cancer Market Share by Application: 2023 VS 2030

Figure 10. Hospitals & Clinic Case Studies

Figure 11. Cancer Treatment Centers Case Studies

Figure 12. Others Case Studies

Figure 13. Drug Delivery in Cancer Report Years Considered

Figure 14. Global Drug Delivery in Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Drug Delivery in Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Drug Delivery in Cancer Market Share by Region: 2023 VS 2030

Figure 17. Global Drug Delivery in Cancer Market Share by Players in 2023

Figure 18. Global Top Drug Delivery in Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery in Cancer as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Drug Delivery in Cancer Revenue in 2023

Figure 20. North America Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Drug Delivery in Cancer Market Share by Country (2019-2030)

Figure 22. United States Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Drug Delivery in Cancer Market Share by Country (2019-2030)

Figure 26. Germany Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Drug Delivery in Cancer Market Share by Region (2019-2030)

Figure 34. China Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Drug Delivery in Cancer Market Share by Country (2019-2030)

Figure 42. Mexico Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Drug Delivery in Cancer Market Share by Country (2019-2030)

Figure 46. Turkey Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Drug Delivery in Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Amgen Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 49. Teva Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 50. UCB (Union Chimique Belge) Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 51. Roche Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 52. Celgene Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 53. Sanofi Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 54. Merck Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 55. Johnson & Johnson Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 56. Takeda Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 57. Gilead Sciences Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 58. Pfizer Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 59. Dr Reddy Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 60. Samyang Biopharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 61. Tolmar Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 62. Astellas Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 63. AMAG Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 64. AstraZeneca Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 65. AbbVie Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 66. Novartis Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 67. Aspen Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 68. Shire (Baxalta) Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 69. Breckenridge Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 70. Galen Pharmaceuticals Revenue Growth Rate in Drug Delivery in Cancer Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Drug Delivery in Cancer Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-10B3055

Global Drug Delivery in Cancer Market Research Report 2024

FEATURED COMPANIES

Drug Delivery in Cancer Market

Report Scope

Scope of Drug Delivery in Cancer Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Drug Delivery in Cancer Market report?

What are the Application segmentation covered in the Drug Delivery in Cancer Market report?

What are the Type segmentation covered in the Drug Delivery in Cancer Market report?

FEATURED COMPANIES